TY - JOUR AU - Chang, Yu-Chi AU - Hsu, Bang-Gee AU - Liou, Hung-Hsiang AU - Lee, Chung-Jen AU - Wang, Ji-Hung PY - 2018 DA - 2018/11/27 TI - Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients JO - BMC Cardiovascular Disorders SP - 214 VL - 18 IS - 1 AB - Sclerostin is known to be a canonical Wnt/β-catenin signaling pathway inhibitor, while the Wnt/β-catenin signaling pathway is proposed to be involved in the development of arterial stiffness. This study aims to investigate the relationship between serum sclerostin levels and carotid–femoral pulse wave velocity (cfPWV) among hypertensive patients. SN - 1471-2261 UR - https://doi.org/10.1186/s12872-018-0955-5 DO - 10.1186/s12872-018-0955-5 ID - Chang2018 ER -